Search for other papers by Anne H van der Spek in
Google Scholar
PubMed
Search for other papers by Olga V Surovtseva in
Google Scholar
PubMed
Search for other papers by Saskia Aan in
Google Scholar
PubMed
Search for other papers by Anton T J Tool in
Google Scholar
PubMed
Search for other papers by Annemarie van de Geer in
Google Scholar
PubMed
Search for other papers by Korcan Demir in
Google Scholar
PubMed
Search for other papers by Anja L M van Gucht in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by Timo K van den Berg in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Anita Boelen in
Google Scholar
PubMed
. Interestingly, elevated circulating IL-8 levels have also been described in hyperthyroidism (both Graves’ disease and toxic multinodular goiter) ( 45 ). Furthermore, T 3 induces IL-8 production in bone marrow stromal cells and a human osteoblast cell line ( 46
Search for other papers by Muthiah Subramanian in
Google Scholar
PubMed
Search for other papers by Manu Kurian Baby in
Google Scholar
PubMed
Search for other papers by Krishna G Seshadri in
Google Scholar
PubMed
Introduction Although antithyroid drugs (ATDs) and partial thyroidectomy have established the treatment modalities, radioiodine therapy has become the primary treatment option of hyperthyroidism in Graves' disease (1, 2) . A number of interrelated
Search for other papers by Adriano N Cury in
Google Scholar
PubMed
Search for other papers by Verônica T Meira in
Google Scholar
PubMed
Pediatric Endocrinology Unit, Endocrinology and Metabolism, Nuclear Medicine Laboratory, Pediatrics Department, Irmandade da Santa Casa de Misericórdia de São Paulo, 01221-020 São Paulo, Brazil
Search for other papers by Osmar Monte in
Google Scholar
PubMed
Search for other papers by Marília Marone in
Google Scholar
PubMed
Search for other papers by Nilza M Scalissi in
Google Scholar
PubMed
Search for other papers by Cristiane Kochi in
Google Scholar
PubMed
Search for other papers by Luís E P Calliari in
Google Scholar
PubMed
Search for other papers by Carlos A Longui in
Google Scholar
PubMed
clinical features and laboratory findings of hyperthyroidism due to GD. At the time that RAI was administered, the patients' ages ranged from 5 to 19 years. The variables that we studied included associated diseases, gender, age, and stage of puberty
Search for other papers by Lian Duan in
Google Scholar
PubMed
Search for other papers by Han-Yu Zhang in
Google Scholar
PubMed
Search for other papers by Min Lv in
Google Scholar
PubMed
Search for other papers by Han Zhang in
Google Scholar
PubMed
Search for other papers by Yao Chen in
Google Scholar
PubMed
Search for other papers by Ting Wang in
Google Scholar
PubMed
Search for other papers by Yan Li in
Google Scholar
PubMed
Search for other papers by Yan Wu in
Google Scholar
PubMed
Search for other papers by Junfeng Li in
Google Scholar
PubMed
Search for other papers by Kefeng Li in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is an autoimmune disease with the overproduction of thyroid-stimulating hormones (TSH) induced by the activation of thyrotropin-receptor antibodies (TRAb) ( 1 ). It is the most common cause of hyperthyroidism
Search for other papers by Eng-Loon Tng in
Google Scholar
PubMed
Search for other papers by Yee Sian Tiong in
Google Scholar
PubMed
Search for other papers by Aye Thida Aung in
Google Scholar
PubMed
Search for other papers by Nicole Ya Yuan Chong in
Google Scholar
PubMed
Search for other papers by Zhemin Wang in
Google Scholar
PubMed
Introduction Atrial fibrillation (AF) occurs in 6–28% of people with hyperthyroidism ( 1 , 2 , 3 , 4 , 5 , 6 ). Thyrotoxicosis increases the activities of thrombin, fibrinogen, factor VIII, factor IX, von Willebrand factor, and tissue
Search for other papers by Chun-feng Lu in
Google Scholar
PubMed
Search for other papers by Wang-shu Liu in
Google Scholar
PubMed
Search for other papers by Xiao-qin Ge in
Google Scholar
PubMed
Search for other papers by Feng Xu in
Google Scholar
PubMed
Search for other papers by Jian-bin Su in
Google Scholar
PubMed
Search for other papers by Xue-qin Wang in
Google Scholar
PubMed
Search for other papers by Yan Wang in
Google Scholar
PubMed
in the treatment of hyperthyroidism partly by inhibiting the activity of ADA, so ADA might be a potential therapeutic target for GD. However, to our knowledge, there are no clinical studies that have explored the relationship between serum ADA levels
Search for other papers by Sarah Christine Sentis in
Google Scholar
PubMed
Search for other papers by Rebecca Oelkrug in
Google Scholar
PubMed
Search for other papers by Jens Mittag in
Google Scholar
PubMed
hormone levels. During mild hypo- or hyperthyroidism, brown fat thermogenesis is adjusted to compensate for the change in obligatory thermogenesis and/or heat loss. In strong hypothyroidism, brown fat function fails entirely. In strong hyperthyroidism, the
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel
Search for other papers by Elena Izkhakov in
Google Scholar
PubMed
Community Division, Clalit Health Services, Tel Aviv, Israel
The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
Search for other papers by Joseph Meyerovitch in
Google Scholar
PubMed
Search for other papers by Micha Barchana in
Google Scholar
PubMed
Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Search for other papers by Yacov Shacham in
Google Scholar
PubMed
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Naftali Stern in
Google Scholar
PubMed
National Cancer Registry, Israel Center for Disease Control, Ministry of Health, Israel, Ramat Gan, Israel
Search for other papers by Lital Keinan-Boker in
Google Scholar
PubMed
retrospective cohort study did reveal increased cerebrovascular events in both hyperthyroid and euthyroid patients treated with radioiodine for benign thyroid disorders ( 21 ). This supports the possible contribution of radioiodine treatment to cerebrovascular
Search for other papers by Selma Flora Nordqvist in
Google Scholar
PubMed
Search for other papers by Victor Brun Boesen in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Search for other papers by Per Karkov Cramon in
Google Scholar
PubMed
Department of Internal Medicine, Herlev Gentofte Hospital, Copenhagen, Denmark
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen, Denmark
Search for other papers by Mogens Groenvold in
Google Scholar
PubMed
National Research Centre for the Working Environment, Copenhagen, Denmark
QualityMetric Incorporated, LLC, Johnston, Rhode Island, USA
Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed
) measures The ThyPRO measures a range of aspects of QoL relevant to patients with benign thyroid disease. It covers not only physical symptoms specifically relevant to thyroid diseases, for example, symptoms of hyperthyroidism and goiter, but also
Department of Endocrinology, Zunyi Medical University, Zunyi, China
Search for other papers by Mengxue Yang in
Google Scholar
PubMed
Search for other papers by Bowen Sun in
Google Scholar
PubMed
Search for other papers by Jianhui Li in
Google Scholar
PubMed
Search for other papers by Bo Yang in
Google Scholar
PubMed
Search for other papers by Jie Xu in
Google Scholar
PubMed
Search for other papers by Xue Zhou in
Google Scholar
PubMed
Search for other papers by Jie Yu in
Google Scholar
PubMed
Search for other papers by Xuan Zhang in
Google Scholar
PubMed
Search for other papers by Qun Zhang in
Google Scholar
PubMed
Search for other papers by Shan Zhou in
Google Scholar
PubMed
Search for other papers by Xiaohua Sun in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is an organ-specific autoimmune thyroid disease (AITD) ( 1 , 2 ) and the most common cause of hyperthyroidism in iodine-sufficient geographical areas ( 3 ). According to the literature, the prevalence of